Blood News and Research

RSS

Researchers discover new mechanism that distinguishes normal blood stem cells from blood cancers

Researchers at Dartmouth's Norris Cotton Cancer Center have published results from a study Cell Reports that discovers a new mechanism that distinguishes normal blood stem cells from blood cancers.

9 May 2014

Children with autism experience deficits in immune cell that protects against infection

Children with autism experience deficits in a type of immune cell that protects the body from infection. Called granulocytes, the cells exhibit one-third the capacity to fight infection and protect the body from invasion compared with the same cells in children who are developing normally.

9 May 2014

Axial Exchange launches new Spanish-language version of mobile application

Axial Exchange, Inc., a pioneer in using mobile applications to deepen the patient's role in improving outcomes, launched a new Spanish-language version of its mobile application, making the company's innovative patient engagement tools available to a greater population.

9 May 2014

New study associates sex difference in brain with MS

A newly identified difference between the brains of women and men with multiple sclerosis (MS) may help explain why so many more women than men get the disease, researchers at Washington University School of Medicine in St. Louis report.

9 May 2014

Study finds ovarian cancer cells are more aggressive on soft tissues due to mechanical properties of environment

When ovarian cancer spreads from the ovaries it almost always does so to a layer of fatty tissue that lines the gut.

9 May 2014

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.

8 May 2014

Sildenafil may help boys suffering from muscular dystrophy disease

Drugs used to treat erectile dysfunction may be able to slow disease progression in boys who suffer from the muscle wasting disease Duchenne muscular dystrophy.

8 May 2014

New technique expands number of functional cord blood stem cells for transplantation

Adults suffering from diseases such as leukemia, lymphoma, and other blood-related disorders may benefit from life-saving treatment commonly used in pediatric patients. Researchers at the Icahn School of Medicine at Mount Sinai have identified a new technique that causes cord blood (CB) stems cells to generate in greater numbers making them more useful in adult transplantation.

8 May 2014

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

8 May 2014

NIH-funded study in tanzanian infants tracked risk of severe malaria over time

Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild.

8 May 2014

WHI: Combined hormone therapy clinical trial yields massive economic return

Economic findings were released today on the Women's Health Initiative (WHI), estrogen plus progestin (E+P) trial.

8 May 2014

First international molecular screening program at IMPAKT for metastatic breast cancer

While research has made great strides in recent decades to improve and significantly extend the lives of patients with early breast cancer, the needs of patients with advanced or metastatic disease have largely been ignored.

8 May 2014

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Cedars-Sinai Heart Institute researchers have found that a commonly prescribed drug restores blood flow to oxygen-starved muscles of boys with Duchenne muscular dystrophy, a genetic muscle-wasting disease that rarely is seen in girls but affects one in 3,500 male babies, profoundly shortening life expectancy. It is the most common fatal disease that affects children.

8 May 2014

Children who spend more hours in front of screen have high blood pressure

A new study reveals that children who spend two hours or more in front of a screen (TV, computer, videogames etc.) have over 2.5 fold increase in their odds of having high blood pressure (BP). These odds are increased further by overweight and obesity.

8 May 2014

Low-carbohydrate diet reduces inflammation in patients with type 2 diabetes

A low-carbohydrate diet, but not a low-fat diet, reduces inflammation in patients with type 2 diabetes, according to research at Linköping University in Sweden.

8 May 2014

Regular doctor visits may reduce melanoma mortality, says study

The risk of dying from the most dangerous type of skin cancer is significantly reduced with regular doctor visits, according to a Henry Ford Hospital study.

8 May 2014

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

A drug typically prescribed for erectile dysfunction or increased pressure in the arteries may help improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to a study published in the May 7, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 May 2014

MinuteClinic walk-in medical clinics open in central Georgia

The first MinuteClinic walk-in medical clinics in central Georgia have opened inside two CVS/pharmacy stores in Macon and one in Warner Robbins.

7 May 2014

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Ligand Pharmaceuticals Incorporated today reported financial results for the three months ended March 31, 2014, and provided an operating forecast and program updates.

7 May 2014

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Lipids, primarily cholesterol and triglycerides, come from two sources: what is naturally manufactured in the liver and what comes from the intestines through the diet.

From Sanofi 7 May 2014

Blood News and Research

Researchers discover new mechanism that distinguishes normal blood stem cells from blood cancers

Children with autism experience deficits in immune cell that protects against infection

Axial Exchange launches new Spanish-language version of mobile application

New study associates sex difference in brain with MS

Study finds ovarian cancer cells are more aggressive on soft tissues due to mechanical properties of environment

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

Sildenafil may help boys suffering from muscular dystrophy disease

New technique expands number of functional cord blood stem cells for transplantation

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

NIH-funded study in tanzanian infants tracked risk of severe malaria over time

WHI: Combined hormone therapy clinical trial yields massive economic return

First international molecular screening program at IMPAKT for metastatic breast cancer

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Children who spend more hours in front of screen have high blood pressure

Low-carbohydrate diet reduces inflammation in patients with type 2 diabetes

Regular doctor visits may reduce melanoma mortality, says study

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

MinuteClinic walk-in medical clinics open in central Georgia

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News